As flu season continues, many people wonder if getting the shot was worth it. Health officials have now shared their first snapshot of how the 2024-2025 vaccine is performing. This early look includes data on how well it's working to prevent doctor's visits and hospitalizations across the United States. It's important to understand what this report is and isn't. These are interim estimates, which means they're based on data collected from October 2024 through February 2025. The report doesn't give us specific numbers on how much the vaccine reduced the risk of getting sick. It also doesn't include statistical measures like confidence intervals, which tell us how precise the estimates are. Because this is an observational study, it shows an association between vaccination and outcomes, but it can't prove the vaccine directly caused the lower illness rates. Other factors could be at play. The findings are a helpful early check-in, but they're not the final word on this year's vaccine's performance.
Interim estimates reported for 2024-2025 seasonal influenza vaccine effectiveness in US patientsHow well is this year's flu shot working? Early data is in
AI-generated summary of the cited source, checked by automated accuracy review. How we work
Key Takeaway
Interpret interim flu vaccine effectiveness estimates cautiously; final data and specific effect sizes are pending.
An interim observational report from the United States provided preliminary estimates of the 2024-2025 seasonal influenza vaccine effectiveness. The study population included patients in outpatient settings and hospitalized patients, with data collected from October 2024 through February 2025. The primary outcome was vaccine effectiveness in outpatient settings, with a secondary outcome assessing effectiveness against flu-associated hospitalizations. The comparator was not reported.
The main results indicate that interim vaccine effectiveness estimates were reported. However, the specific effect size, absolute numbers, p-values, confidence intervals, and direction of effect were not reported in this interim analysis. No data on safety, adverse events, serious adverse events, discontinuations, or tolerability were provided.
Key limitations include the preliminary nature of the interim estimates. The observational study design means findings show association, not causation. Specific practice relevance was not reported. Clinicians should interpret these interim estimates cautiously, as they lack the statistical detail needed for definitive conclusions and await final analysis.
What this means for you:
First look at this flu season's vaccine is out, but the numbers are still preliminary. More on Influenza
High-dose quadrivalent influenza vaccine shows non-inferior immunogenicity in Chinese children aged 6 to 35 months
High-dose flu shots show greater protection for young children in China
This randomized, double-blind study in 3,000 Chinese children aged 6 to 35 months found an investigational high-dose quadrivalent influenza …
A new study in China shows high-dose flu vaccines work as well as or better than standard shots for toddlers, offering stronger protection a…
mRNA-1010 shows superior efficacy against influenza in older adults
New flu shot cuts illness by 27 percent in adults over 50
A phase 3 trial found mRNA-1010 vaccine had 26.6% relative efficacy versus standard comparator in adults 50+.
A new mRNA flu vaccine reduced confirmed flu illness by 27 percent compared with the standard shot in adults 50 and older.
Systematic review and meta-analysis finds bacterial co-infection in 17.3% of hospitalized influenza patients
Hospital data shows high rates of bacterial co-infection in influenza patients
This systematic review and meta-analysis of 111,889 hospital-attended patients with laboratory-confirmed influenza found a pooled prevalence…
Analysis of over 111,000 patients reveals that bacterial co-infection occurs in 17.3% of hospital cases with confirmed influenza infection.
Six H5N1 vaccine formulations showed immunogenicity and acceptable safety in 420 healthy children aged 6 months to 9 years
Higher adjuvant content boosts immunity in children without added safety risks
This phase 2, observer-blind, multicenter study evaluated six formulations of MF59-adjuvanted H5N1 vaccine in 420 healthy infants and childr…
A Phase 2 trial in healthy children found that higher adjuvant content improved immune responses to an H5N1 vaccine without increasing side …
View Original Abstract ↓
This report describes interim 2024-2025 seasonal flu vaccine effectiveness estimates in outpatient settings and against flu-associated hospitalizations.
Intrawound tobramycin plus vancomycin did not reduce deep infection risk compared with vancomycin alone in high-risk tibial fractures
Adding Antibiotics to Bone Surgery Didn't Lower Infection Risk
Related in Infectious Disease
FDA Approves Linezolid Injection for Gram-Positive Infections Including Pneumonia and Skin Infections
FDA approves new antibiotic injection for serious bacterial infections
The FDA approved linezolid injection for nosocomial pneumonia, community-acquired pneumonia, complicated skin infections, and vancomycin-res…
The FDA approved linezolid injection for treating serious infections like pneumonia and skin infections caused by certain bacteria, includin…
Intrawound vancomycin powder reduces postoperative infection risk (OR 0.59) in high-risk fracture fixation cases
Vancomycin Powder May Reduce Infections After High Risk Fractures
This meta-analysis of 3185 patients found that intrawound vancomycin powder significantly reduced postoperative infection rates (OR 0.59; 95…
A review of data suggests that using vancomycin powder in wounds may lower infection rates for patients with serious bone fractures.
Risk-adapted HLA delisting and imlifidase enable deceased-donor kidney transplantation for highly sensitized candidates
New guide helps transplant kidneys for hardest-to-match patients
This expert consensus provides a practical guideline for managing highly sensitized adult patients on the waitlist for deceased-donor kidney…
A new expert guide shows how to safely transplant kidneys into highly sensitized patients who have few options left.
Regenerative endodontic procedures may lead to unusual root morphology in immature teeth
Regenerative procedures can lead to unusual tooth root growth
This case report with literature review describes 2 immature teeth with pulp necrosis secondary to dens evaginatus treated with regenerative…
A new look at dental treatments shows that while some procedures save teeth, they can sometimes cause unexpected changes in how roots grow.
From Other Specialties
Post-extubation dysphagia incidence ranges from 28.36% to 68.94% in critically ill children
High rates of swallowing problems found in children after intubation
This scoping review of 15 studies examines the incidence and predictors of pediatric post-extubation dysphagia (PED). The authors identify h…
Many critically ill children struggle to swallow safely after breathing tubes are removed, with some studies showing issues in up to 69% of …
Circular RNAs may regulate ferroptosis and anti-tumor immunity in cancer via multiple mechanisms
Circular RNAs may offer new ways to target cancer cells
This systematic review explores how circular RNAs (circRNAs) act as molecular bridges to simultaneously regulate ferroptosis and anti-tumor …
New research identifies circular RNAs as molecular bridges that could help doctors diagnose and treat cancer more precisely.
Meningeal Immune System Offers New Target for Glioblastoma Immunotherapy
New approach targets the immune system to treat brain tumors
This systematic review explores how targeting the meningeal immune system, including dural lymphatics and rBAMs, could overcome current barr…
A new strategy focuses on the area where brain tumors meet the body's defenses to improve how immunotherapy works for glioblastoma.
A 6 dimension and 42 item system provides early risk assessment for high-risk diabetic feet
Experts Develop New Risk Assessment System for Diabetic Feet
This expert consultation and guideline describes the development of an early risk assessment system for high-risk diabetic feet. The consens…
A new assessment system identifies risk factors like nerve damage and circulation to help manage and prevent complications in patients with …